- Home
- ZENV vs PDSB Comparison
ZENV vs PDSB Comparison
Compare ZENV & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZENV
- PDSB
- Stock Information
- Founded
- ZENV 2005
- PDSB 2005
- Country
- ZENV Brazil
- PDSB United States
- Employees
- ZENV N/A
- PDSB N/A
- Industry
- ZENV Computer Software: Prepackaged Software
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- ZENV Technology
- PDSB Health Care
- Exchange
- ZENV Nasdaq
- PDSB Nasdaq
- Market Cap
- ZENV 79.2M
- PDSB 72.2M
- IPO Year
- ZENV 2021
- PDSB N/A
- Fundamental
- Price
- ZENV $1.49
- PDSB $1.35
- Analyst Decision
- ZENV
- PDSB Strong Buy
- Analyst Count
- ZENV 0
- PDSB 2
- Target Price
- ZENV N/A
- PDSB $10.00
- AVG Volume (30 Days)
- ZENV 87.2K
- PDSB 516.6K
- Earning Date
- ZENV 07-02-2025
- PDSB 08-12-2025
- Dividend Yield
- ZENV N/A
- PDSB N/A
- EPS Growth
- ZENV N/A
- PDSB N/A
- EPS
- ZENV N/A
- PDSB N/A
- Revenue
- ZENV $181,911,572.00
- PDSB N/A
- Revenue This Year
- ZENV $8.58
- PDSB N/A
- Revenue Next Year
- ZENV $8.83
- PDSB N/A
- P/E Ratio
- ZENV N/A
- PDSB N/A
- Revenue Growth
- ZENV 23.99
- PDSB N/A
- 52 Week Low
- ZENV $1.02
- PDSB $0.85
- 52 Week High
- ZENV $3.03
- PDSB $4.42
- Technical
- Relative Strength Index (RSI)
- ZENV 44.62
- PDSB 41.32
- Support Level
- ZENV $1.45
- PDSB $1.18
- Resistance Level
- ZENV $1.59
- PDSB $1.66
- Average True Range (ATR)
- ZENV 0.16
- PDSB 0.11
- MACD
- ZENV -0.01
- PDSB -0.05
- Stochastic Oscillator
- ZENV 16.96
- PDSB 22.42
About ZENV Zenvia Inc.
Zenvia Inc provides a platform that enables companies to create journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.